NEW YORK – The use of p16 profiling to indirectly detect human papillomavirus (HPV)-related cancers of the oropharynx may fail to pick up a subset of HPV-positive cases, according to early results from the EPIC-OPC study.
NEW YORK – The use of p16 profiling to indirectly detect human papillomavirus (HPV)-related cancers of the oropharynx may fail to pick up a subset of HPV-positive cases, according to early results from the EPIC-OPC study.
Premium Access gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
You may already have institutional access!
Already a Precision Oncology News or 360Dx or GenomeWeb Premium member?
Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.